Help | RSS Feed



Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) Seasonal Chart

Seasonal Chart Analysis

Analysis of the Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) seasonal charts above shows that a Buy Date of November 8 and a Sell Date of January 30 has resulted in a geometric average return of 5.49% above the benchmark rate of the S&P 500 Total Return Index over the past 20 years. This seasonal timeframe has shown positive results compared to the benchmark in 16 of those periods. This is a very good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 20 years by an average of 9.76% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Teva Pharmaceutical Industries Ltd is the largest generic drug manufacturer in the world with more than 60 manufacturing and R&D facilities, headquartered in Israel. The company was formed in 1901 and has a portfolio of more than 3,500 medicines–roughly one out of nine generic prescriptions in the U.S. is filled with a Teva product. The company also develops branded pharmaceuticals in the central nervous system, oncology, and respiratory categories. Teva’s generic drug sales represent about half of total revenue, with branded drug and distribution revenue making up the balance. Teva is an aggressive filer to bring generic drugs to market when brand patents expire and has the most generic products pending FDA approval.

To download TEVA seasonal chart data, please log in or Subscribe.

 

Stocks mentioned in this post:

    Search Seasonal Charts by Symbol, Company, or Term

   Symbols by Letter: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z


Sponsored By...
Seasonal Advantage Portfolio by CastleMoore